Your browser doesn't support javascript.
loading
Effects of Dimethyl Fumarate on Brain Atrophy in Relapsing-Remitting Multiple Sclerosis: Pooled Analysis Phase 3 DEFINE and CONFIRM Studies.
Nakamura, Kunio; Mokliatchouk, Oksana; Arnold, Douglas L; Yousry, Tarek A; Kappos, Ludwig; Richert, Nancy; Ayling-Rouse, Katherine; Miller, Catherine; Fisher, Elizabeth.
Afiliação
  • Nakamura K; Department of Biomedical Engineering, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, United States.
  • Mokliatchouk O; Biogen, Cambridge, MA, United States.
  • Arnold DL; McConnell Brain Imaging Center, Montreal Neurological Institute, McGill University, Montreal, QC, Canada.
  • Yousry TA; Lysholm Department of Neuroradiology, National Hospital for Neurology and Neurosurgery, University College London Institute of Neurology, London, United Kingdom.
  • Kappos L; Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), Departments of Medicine, Clinical Research, Biomedicine and Biomedical Engineering, University Hospital and University of Basel, Basel, Switzerland.
  • Richert N; Biogen, Cambridge, MA, United States.
  • Ayling-Rouse K; Envision Pharma Group, Horsham, United Kingdom.
  • Miller C; Biogen, Cambridge, MA, United States.
  • Fisher E; Biogen, Cambridge, MA, United States.
Front Neurol ; 13: 809273, 2022.
Article em En | MEDLINE | ID: mdl-35370887
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Revista: Front Neurol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Revista: Front Neurol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos